Grantham, Mayo, Van Otterloo & Co (GMO)’s VEON VEON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,036
Closed -$12.7K 768
2022
Q4
$12.7K Sell
1,036
-5,580
-84% -$60K ﹤0.01% 706
2022
Q3
$53K Hold
6,616
﹤0.01% 707
2022
Q2
$76K Sell
6,616
-13,112
-66% -$175K ﹤0.01% 732
2022
Q1
$4K Buy
19,728
+4,684
+31% +$127K ﹤0.01% 686
2021
Q4
$643K Buy
15,044
+6,456
+75% +$315K ﹤0.01% 577
2021
Q3
$447K Buy
+8,588
New +$413K ﹤0.01% 605
2018
Q2
Sell
-36,688
Closed -$2.42M 619
2018
Q1
$2.42M Buy
36,688
+208
+0.6% +$17.4K 0.01% 297
2017
Q4
$3.5M Buy
+36,480
New +$3.57M 0.02% 271
2017
Q2
Sell
-4,075
Closed -$416K 633
2017
Q1
$416K Sell
4,075
-126,545
-97% -$13M ﹤0.01% 412
2016
Q4
$12.6M Sell
130,620
-51,188
-28% -$4.43M 0.07% 173
2016
Q3
$15.8M Sell
181,808
-13,608
-7% -$1.37M 0.07% 177
2016
Q2
$19M Sell
195,416
-23,252
-11% -$2.18M 0.08% 173
2016
Q1
$23.3M Buy
218,668
+72,912
+50% +$6.44M 0.09% 174
2015
Q4
$12M Buy
145,756
+96,796
+198% +$8.75M 0.04% 189
2015
Q3
$5.04M Buy
+48,960
New +$6.12M 0.02% 240
2015
Q2
Sell
-34,252
Closed -$4.49M 451
2015
Q1
$4.49M Sell
34,252
-20,164
-37% -$2.38M 0.01% 274
2014
Q4
$5.68M Sell
54,416
-39,460
-42% -$5.35M 0.02% 246
2014
Q3
$16.9M Buy
93,876
+10,204
+12% +$2.14M 0.04% 166
2014
Q2
$17.6M Buy
83,672
+8,376
+11% +$1.76M 0.05% 155
2014
Q1
$17M Buy
75,296
+13,280
+21% +$3.41M 0.04% 164
2013
Q4
$20.1M Buy
62,016
+15,824
+34% +$5.06M 0.05% 145
2013
Q3
$13.6M Buy
46,192
+41,748
+939% +$11.1M 0.04% 175
2013
Q2
$1.12M Buy
+4,444
New +$1.21M ﹤0.01% 450

Other funds holding VEON

Grantham, Mayo, Van Otterloo & Co (GMO)'s VEON Position: Q1 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of VEON (VEON) in Q1 2023, closing a stake of 1,036 shares — an estimated $12.7K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VEON in Q2 2013 and held it in 23 quarters. The position peaked at $23.3M in Q1 2016. 41 funds tracked by Wall St. Rank hold VEON as of Q1 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining VEON position as of Q1 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,036 VEON shares in Q1 2023, an estimated $12.7K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VEON in Q2 2013 and held it in 23 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s VEON position peaked at $23.3M in Q1 2016.
  • 41 funds tracked by Wall St. Rank held VEON as of Q1 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.